首頁
關於美商安美睿
服務項目
新聞發布
最新消息
COVID-19
相關文件
聯絡我們
安美睿&NSF
相關連結
More...
Dec 17, 2014
Amarex Clinical Research Site Passes Surprise FDA Audit for a Multicenter, Randomized-Controlled Clinical Trial in Surgical Wound Healing and Cosmesis Study Submitted to FDA for Approval
Dec 10, 2014
Amarex and SyneuRx announce FDA approval of Breakthrough designation for Schizophrenia treatment
Nov 12, 2014
Amarex achieves exceptionally fast enrollment completion, ahead of schedule, for a Diabetic Neuropathy Clinical Trial
◄
1 / 3
►
Dec 04, 2013
Amarex Founder and CEO Dr. Kazem Kazempour appointed to George Washington University's Regulatory Affairs Advisory Board
Oct 08, 2013
Successful FDA Meeting Advances Botonical Drug to Phase II Study
Sep 14, 2013
Amarex and Montgomery College are again collaborating! The Clinical Trial Project Management course begins on this date
1 / 2